{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:52:20Z","timestamp":1775695940252,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Community\u2019s Seventh Framework Programme","award":["FP7-HEALTH-F5-2009-241783"],"award-info":[{"award-number":["FP7-HEALTH-F5-2009-241783"]}]},{"name":"Research Center of Portuguese Oncology Institute of Porto","award":["PI 74-CI-IPOP-19-2016"],"award-info":[{"award-number":["PI 74-CI-IPOP-19-2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00432-018-2733-2","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T10:10:47Z","timestamp":1534155047000},"page":"2127-2137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer"],"prefix":"10.1007","volume":"144","author":[{"given":"S\u00f3nia","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Micaela","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Monteiro-Reis","sequence":"additional","affiliation":[]},{"given":"Marcia","family":"Vieira-Coimbra","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Paulino","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Fl\u00e1vio","family":"Videira","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"2733_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683\u2013691. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2015-310912","journal-title":"Gut"},{"key":"2733_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/1471-2407-14-531","volume":"14","author":"A Benard","year":"2014","unstructured":"Benard A, Goossens-Beumer IJ, van Hoesel AQ, de Graaf W, Horati H, Putter H, Zeestraten EC, van de Velde CJ, Kuppen PJ (2014a) Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer. BMC Cancer 14:531. \n                    https:\/\/doi.org\/10.1186\/1471-2407-14-531","journal-title":"BMC Cancer"},{"key":"2733_CR3","doi-asserted-by":"publisher","first-page":"e108265","DOI":"10.1371\/journal.pone.0108265","volume":"9","author":"A Benard","year":"2014","unstructured":"Benard A, Goossens-Beumer IJ, van Hoesel AQ, Horati H, Putter H, Zeestraten EC, van de Velde CJ, Kuppen PJ (2014b) Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer. PLoS One 9:e108265. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0108265","journal-title":"PLoS One"},{"key":"2733_CR4","doi-asserted-by":"publisher","first-page":"19609","DOI":"10.18632\/oncotarget.14778","volume":"8","author":"J Chen","year":"2017","unstructured":"Chen J, Ding J, Wang Z, Zhu J, Wang X, Du J (2017) Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells. Oncotarget 8:19609\u201319630. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14778","journal-title":"Oncotarget"},{"key":"2733_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1158\/1541-7786.MCR-13-0546","volume":"12","author":"G Deb","year":"2014","unstructured":"Deb G, Singh AK, Gupta S (2014) EZH2: not EZHY (easy) to deal. Mol Cancer Res 12:639\u2013653. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0546","journal-title":"Mol Cancer Res"},{"key":"2733_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/carcin\/bgp073","volume":"30","author":"S Derks","year":"2009","unstructured":"Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van der Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruine AP, Herman JG, van Engeland M (2009) Promoter CpG island hypermethylation-and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis 30:1041\u20131048. \n                    https:\/\/doi.org\/10.1093\/carcin\/bgp073","journal-title":"Carcinogenesis"},{"key":"2733_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bjc.2013.364","volume":"109","author":"J Ding","year":"2013","unstructured":"Ding J, Zhang ZM, Xia Y, Liao GQ, Pan Y, Liu S, Zhang Y, Yan ZS (2013) LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer. Br J Cancer 109:994\u20131003. \n                    https:\/\/doi.org\/10.1038\/bjc.2013.364","journal-title":"Br J Cancer"},{"key":"2733_CR8","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386. \n                    https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"2733_CR9","doi-asserted-by":"publisher","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE (2017) Epigenetic plasticity and the hallmarks of cancer. Science 357:eaal2380. \n                    https:\/\/doi.org\/10.1126\/science.aal2380","journal-title":"Science"},{"key":"2733_CR10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/sj.bjc.6605333","volume":"101","author":"\u00d8 Fluge","year":"2009","unstructured":"Fluge \u00d8, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM, Otte AP, Akslen LA, Dahl O, Norwegian Gastrointestinal Cancer Group (2009) Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer 101:1282\u20131289. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6605333","journal-title":"Br J Cancer"},{"key":"2733_CR11","first-page":"134","volume-title":"WHO Classification of tumours of the digestive system","author":"SR Hamilton","year":"2010","unstructured":"Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H, Nakamura SI, Quirke P, Riboli E, Sobin LH (2010) Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO Classification of tumours of the digestive system, 4th\u00a0edn. IARC, Lyon 2010, pp\u00a0134\u2013146","edition":"4"},{"key":"2733_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/cas.13004","volume":"107","author":"S Hino","year":"2016","unstructured":"Hino S, Kohrogi K, Nakao M (2016) Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells. Cancer Sci 107:1187\u20131192. \n                    https:\/\/doi.org\/10.1111\/cas.13004","journal-title":"Cancer Sci"},{"key":"2733_CR13","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.ejca.2015.07.024","volume":"51","author":"B Holleczek","year":"2015","unstructured":"Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, Hackl M, Eisemann N, Brenner H, EUROCARE-5 Working Group (2015) On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999\u20132007\u2013Results from the EUROCARE-5 study. Eur J Cancer 51:2158\u20132168. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2015.07.024","journal-title":"Eur J Cancer"},{"key":"2733_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2217\/epi-2017-0022","volume":"9","author":"A Hosseini","year":"2017","unstructured":"Hosseini A, Minucci S (2017) A comprehensive review of lysine-specific demethylase 1 and its roles in cancer. Epigenomics 9:1123\u20131142. \n                    https:\/\/doi.org\/10.2217\/epi-2017-0022","journal-title":"Epigenomics"},{"key":"2733_CR15","doi-asserted-by":"publisher","first-page":"e70077","DOI":"10.1371\/journal.pone.0070077","volume":"8","author":"Z Huang","year":"2013","unstructured":"Huang Z, Li S, Song W, Li X, Li Q, Zhang Z, Han Y, Zhang X, Miao S, Du R, Wang L (2013) Lysine-specific demethylase 1 (LSD1\/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt\/\u03b2-catenin pathway by down-regulating Dickkopf-1 (DKK1). PloS One 8:e70077. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0070077","journal-title":"PloS One"},{"key":"2733_CR16","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.18632\/oncotarget.6612","volume":"7","author":"T Jiang","year":"2016","unstructured":"Jiang T, Wang Y, Zhou F, Gao G, Ren S, Zhou C (2016) Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis. Oncotarget 7:4584\u20134597. \n                    https:\/\/doi.org\/10.18632\/oncotarget.6612","journal-title":"Oncotarget"},{"key":"2733_CR17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s10620-012-2552-2","volume":"58","author":"D Jie","year":"2013","unstructured":"Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi Z, Jing W, Liang Z (2013) Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig Dis Sci 58:1581\u20131589. \n                    https:\/\/doi.org\/10.1007\/s10620-012-2552-2","journal-title":"Dig Dis Sci"},{"key":"2733_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/BJ20121360","volume":"449","author":"L Jin","year":"2013","unstructured":"Jin L, Hanigan CL, Wu Y, Wang W, Park BH, Woster PM, Casero RA (2013) Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53-and DNMT1 (DNA methyltransferase 1)-independent manner. Biochem J 449:459\u2013468. \n                    https:\/\/doi.org\/10.1042\/BJ20121360","journal-title":"Biochem J"},{"key":"2733_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa JP, Baylin S (2016) Targeting the cancer epigenome for therapy. Nat Rev Genet 17:630\u2013641. \n                    https:\/\/doi.org\/10.1038\/nrg.2016.93","journal-title":"Nat Rev Genet"},{"key":"2733_CR20","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1172\/JCI61216","volume":"122","author":"HA Kim","year":"2012","unstructured":"Kim HA, Koo BK, Cho JH, Kim YY, Seong J, Chang HJ, Oh YM, Stange DE, Park JG, Hwang D, Kong YY (2012) Notch1 counteracts WNT\/\u03b2-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest 122:3248\u20133259. \n                    https:\/\/doi.org\/10.1172\/JCI61216","journal-title":"J Clin Invest"},{"key":"2733_CR21","doi-asserted-by":"publisher","first-page":"12704","DOI":"10.18632\/oncotarget.7260","volume":"7","author":"H Kurihara","year":"2016","unstructured":"Kurihara H, Maruyama R, Ishiguro K, Kanno S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma T, Sukawa Y, Okita K, Hasegawa T, Imai K, Yamamoto H, Shinomura Y, Nosho K (2016) The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway. Oncotarget 7:12704\u201312717. \n                    https:\/\/doi.org\/10.18632\/oncotarget.7260","journal-title":"Oncotarget"},{"key":"2733_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00432-014-1854-5","volume":"141","author":"YL Liu","year":"2015","unstructured":"Liu YL, Gao X, Jiang Y, Zhang G, Sun ZC, Cui BB, Yang YM (2015) Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer. J Cancer Res Clin Oncol 141:661\u2013669. \n                    https:\/\/doi.org\/10.1007\/s00432-014-1854-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"2733_CR23","first-page":"2737","volume":"6","author":"H Lu","year":"2016","unstructured":"Lu H, Li G, Zhou C, Jin W, Qian X, Wang Z, Pan H, Jin H, Wang X (2016) Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development. Am J Cancer Res 6:2737\u20132754","journal-title":"Am J Cancer Res"},{"key":"2733_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/1748-717X-9-188","volume":"9","author":"X Meng","year":"2014","unstructured":"Meng X, Huang Z, Wang R, Jiao Y, Li H, Xu X, Feng R, Zhu K, Jiang S, Yan H, Yu J (2014) The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Radiat Oncol 9:188. \n                    https:\/\/doi.org\/10.1186\/1748-717X-9-188","journal-title":"Radiat Oncol"},{"key":"2733_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ejso.2004.11.001","volume":"31","author":"K Mimori","year":"2005","unstructured":"Mimori K, Ogawa K, Okamoto M, Sudo T, Inoue H, Mori M (2005) Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases. Eur J Surg Oncol 31:376\u2013380. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2004.11.001","journal-title":"Eur J Surg Oncol"},{"key":"2733_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/onc.2015.134","volume":"35","author":"MM Olcina","year":"2016","unstructured":"Olcina MM, Leszczynska KB, Senra JM, Isa NF, Harada H, Hammond EM (2016) H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Oncogene 35:793\u2013799. \n                    https:\/\/doi.org\/10.1038\/onc.2015.134","journal-title":"Oncogene"},{"key":"2733_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbcan.2017.09.003","volume":"1868","author":"A Puccini","year":"2017","unstructured":"Puccini A, Berger MD, Naseem M, Tokunaga R, Battaglin F, Cao S, Hanna DL, McSkane M, Soni S, Zhang W, Lenz HJ (2017) Colorectal cancer: Epigenetic alterations and their clinical implications. Biochim Biophys Acta 1868:439\u2013448. \n                    https:\/\/doi.org\/10.1016\/j.bbcan.2017.09.003","journal-title":"Biochim Biophys Acta"},{"key":"2733_CR28","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1083\/jcb.201710068","volume":"216","author":"L Robbez-Masson","year":"2017","unstructured":"Robbez-Masson L, Tie CH, Rowe HM (2017) Cancer cells, on your histone marks, get SETDB1, silence retrotransposons, and go! J Cell Biol 216:3429\u20133431. \n                    https:\/\/doi.org\/10.1083\/jcb.201710068","journal-title":"J Cell Biol"},{"key":"2733_CR29","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/annonc\/mds236","volume":"23","author":"HJ Schmoll","year":"2012","unstructured":"Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Kohne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshceryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol 23:2479\u20132516. \n                    https:\/\/doi.org\/10.1093\/annonc\/mds236","journal-title":"Ann Oncol"},{"key":"2733_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67:177\u2013193. \n                    https:\/\/doi.org\/10.3322\/caac.21395","journal-title":"CA Cancer J Clin"},{"key":"2733_CR31","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1349-7006.2011.01958.x","volume":"102","author":"M Takawa","year":"2011","unstructured":"Takawa M, Masuda K, Kunizaki M, Daigo Y, Takagi K, Iwai Y, Cho HS, Toyokawa G, Yamane Y, Maejima K, Field HI, Kobayashi T, Akasu T, Sugiyama M, Tsuchiya E, Atomi Y, Ponder BA, Nakamura Y, Hamamoto R (2011) Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci 102:1298\u20131305. \n                    https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01958.x","journal-title":"Cancer Sci"},{"key":"2733_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ejso.2013.02.023","volume":"39","author":"H Tamagawa","year":"2013","unstructured":"Tamagawa H, Oshima T, Numata M, Yamamoto N, Shiozawa M, Morinaga S, Nakamura Y, Yoshihara M, Sakuma Y, Kameda Y, Akaike M, Yukawa N, Rino Y, Masusa M, Miyagi Y (2013) Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer. Eur J Surg Oncol 39:655\u2013661. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2013.02.023","journal-title":"Eur J Surg Oncol"},{"key":"2733_CR33","doi-asserted-by":"publisher","first-page":"e1324","DOI":"10.1038\/cddis.2014.283","volume":"5","author":"J Tan","year":"2014","unstructured":"Tan J, Yang X, Jiang X, Zhou J, Li Z, Lee PL, Li B, Robson P, Yu Q (2014) Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer. Cell Death Dis 5:e1324. \n                    https:\/\/doi.org\/10.1038\/cddis.2014.283","journal-title":"Cell Death Dis"},{"key":"2733_CR34","doi-asserted-by":"publisher","first-page":"13806","DOI":"10.1038\/s41598-017-13670-z","volume":"7","author":"L Vilorio-Marqu\u00e9s","year":"2017","unstructured":"Vilorio-Marqu\u00e9s L, Mart\u00edn V, Diez-Tasc\u00f3n C, Gonz\u00e1lez-Sevilla MF, Fern\u00e1ndez-Villa T, Honrado E, Davila-Batista V, Molina AJ (2017) The role of EZH2 in overall survival of colorectal cancer: a meta-analysis. Sci Rep 7:13806. \n                    https:\/\/doi.org\/10.1038\/s41598-017-13670-z","journal-title":"Sci Rep"},{"key":"2733_CR35","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3748\/wjg.v16.i19.2421","volume":"16","author":"CG Wang","year":"2010","unstructured":"Wang CG, Ye YJ, Yuan J, Liu FF, Zhang H, Wang S (2010) EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. World J Gastroenterol 16:2421\u20132427. \n                    https:\/\/doi.org\/10.3748\/wjg.v16.i19.2421","journal-title":"World J Gastroenterol"},{"key":"2733_CR36","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.jmb.2016.10.012","volume":"429","author":"M Wassef","year":"2016","unstructured":"Wassef M, Margueron R (2016) The multiple facets of PRC2 alterations in cancers. J Mol Biol 429:1978\u20131993. \n                    https:\/\/doi.org\/10.1016\/j.jmb.2016.10.012","journal-title":"J Mol Biol"},{"key":"2733_CR37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/cas.12166","volume":"104","author":"Y Yokoyama","year":"2013","unstructured":"Yokoyama Y, Hieda M, Nishioka Y, Matsumoto A, Higashi S, Kimura H, Yamamoto H, Mori M, Matsuura S, Matsuura N (2013) Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo. Cancer Sci 104:889\u2013895. \n                    https:\/\/doi.org\/10.1111\/cas.12166","journal-title":"Cancer Sci"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-018-2733-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2733-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2733-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:19:03Z","timestamp":1565637543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-018-2733-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2733"],"URL":"https:\/\/doi.org\/10.1007\/s00432-018-2733-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"28 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}